Jason Fontenot
Net worth: 76 856 $ as of 31/05/2024
Network origin in Jason Fontenot first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 35 | |
| Subsidiary | Biotechnology | 20 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jason Fontenot via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| CELGENE | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Administrative Officer Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Investor Relations Contact | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Kosan Biosciences, Inc.
 Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
| CYTOKINETICS, INCORPORATED | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| CODEXIS, INC. | Chemicals: Specialty | Director/Board Member Chief Executive Officer | |
| AMYRIS, INC. | Chemicals: Specialty | Director/Board Member General Counsel | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
AbGenomics International, Inc.
 AbGenomics International, Inc. Pharmaceuticals: MajorHealth Technology AbGenomics International, Inc. manufactures biopharmaceutical therapeutics. The firm produces therapeutics for the treatment of cancer and immune related inflammatory diseases. It also performs research discovery, preclinical and clinical development, as well as strategic planning for commercialization of its therapeutics. The company was founded by Rong-Hwa Lin in 2000 and is headquartered in Los Altos, CA. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
PharmAkea, Inc.
 PharmAkea, Inc. Pharmaceuticals: MajorHealth Technology PharmAkea, Inc. develops small molecule drug candidates against protein targets involved in fibro proliferative diseases. It discovers and develops small molecule therapeutics directed at cancer and fibrotic diseases. The company was founded by John Howard Hutchinson, Kevin Holme, and Jilly Evans in 2012 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree | |
| Stanford University | College/University | Graduate Degree Corporate Officer/Principal Undergraduate Degree Graduate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Doctorate Degree Doctorate Degree | |
| MORPHOSYS AG | Biotechnology | Corporate Officer/Principal Director of Finance/CFO | |
| University of Oxford | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Graduate Degree | |
| University of Cambridge | College/University | Graduate Degree Doctorate Degree | |
| Rutgers State University of New Jersey | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| San Jose State University | College/University | Masters Business Admin Undergraduate Degree | |
| University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
| University College London | College/University | Doctorate Degree Undergraduate Degree | |
| The Royal College of Physicians | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
The State Bar of California
 The State Bar of California Miscellaneous Commercial ServicesCommercial Services The State Bar of California operates as an official attorney licensing agency. The non-profit company is based in San Francisco, CA. Elizabeth Rindskopf Parker has been the CEO of the company since 2015. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Private Equity Investor | |
| AUDENTES THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Human Resources Officer | |
| ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Doctorate Degree Undergraduate Degree | |
| DENALI THERAPEUTICS INC. | Biotechnology | Director/Board Member Founder | |
Sidecar Therapeutics, Inc.
 Sidecar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sidecar Therapeutics, Inc. operates as a biotechnology and pharmaceutical company. It focuses on drug development for fibrotic disease. The company was founded in 2016 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
| VIR BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| JW (CAYMAN) THERAPEUTICS CO. LTD | Biotechnology | Director/Board Member Director/Board Member | |
| SANA BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
Altrubio, Inc.
 Altrubio, Inc. Internet RetailRetail Trade Altrubio, Inc. is a clinical-stage biotechnology company based in Redwood City, CA. The company specializes in developing novel therapies leveraging immune checkpoint agonism to enhance the function of natural pathways to downregulate an overactivated immune system. Altrubio's pipeline includes two clinical stage product candidates: neihulizumab, an immune checkpoint agonist antibody targeting PSGl-1/CD162 that depletes unwanted activated T cells with proof of mechanism in four autoimmune and inflammatory diseases, and ABGN-107, an antibody-drug conjugate employing a unique enzyme cleavable hydrophilic self-immolative linker and targeting a gastrointestinal tumor antigen. The company was founded in 2000, and the CEO is Judy Chou. | Internet Retail | Chairman Director/Board Member | |
DOT Therapeutics-2, Inc.
 DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Founder | |
| DAY ONE BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
| LYELL IMMUNOPHARMA, INC. | Biotechnology | General Counsel Chief Tech/Sci/R&D Officer | |
| THIRD HARMONIC BIO, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Administrative Officer | |
| Neuvogen, Inc. | Director/Board Member Director/Board Member |
Statistics
International
| United States | 45 |
| United Kingdom | 5 |
| Germany | 2 |
| China | 2 |
Sectoral
| Health Technology | 29 |
| Consumer Services | 16 |
| Process Industries | 3 |
| Commercial Services | 3 |
| Finance | 2 |
Operational
| Director/Board Member | 175 |
| Corporate Officer/Principal | 126 |
| Independent Dir/Board Member | 69 |
| Chief Tech/Sci/R&D Officer | 64 |
| Undergraduate Degree | 52 |
Most connected contacts
| Insiders | |
|---|---|
| Joseph Zakrzewski | 30 |
| Patrick Yang | 28 |
| Jay Flatley | 27 |
| Stéphane Boissel | 24 |
| Marc Tessier-Lavigne | 24 |
| Sona Saira Ramasastry | 19 |
| Roger Jeffs | 18 |
| Sunil Agarwal | 17 |
| Steven Mento | 16 |
| Ann Lee | 15 |
| Stephen Dilly | 15 |
| Rupert Vessey | 13 |
| Peg Horn | 12 |
| Lisa Rojkjaer | 12 |
| Corazon Sanders | 12 |
- Stock Market
- Insiders
- Jason Fontenot
- Company connections
